StonvexLoading…
StonvexStonvexStonvexCore line items from SSNC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.27B | $5.88B | $5.50B | $5.28B |
Operating Income | $1.44B | $1.34B | $1.21B | $1.14B |
Net Income | $796.90M | $760.50M | $607.10M | $650.20M |
EPS (Diluted) | $3.15 | $3.00 | $2.39 | $2.48 |
Total Assets | $20.71B | $19.04B | $18.10B | $16.65B |
Total Liabilities | $13.77B | $12.44B | $11.70B | $10.55B |
Cash & Equivalents | $462.10M | $567.10M | $432.20M | $440.10M |
Free Cash Flow OCF − CapEx | $1.66B | $1.33B | $1.16B | $1.07B |
Shares Outstanding | 241.40M | 244.50M | 246.60M | 251.00M |